UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer

Summary

Iressa \[epidermal growth factor tyrosine kinase inhibitor (EGFR-TKI)\] has been reported to activity against Non-small-cell Lung Cancer (NSCLC) failed previous chemotherapy. UFUR was found to have anti-angiogenesis effect when long term treatment was given. Combination of EGFR-TKI and anti-angiogenesis agents is a novel treatment.

Timeline

Start

2005-11

Primary completion

2009-12

Completion

2009-12

Drugs

Indications